Oxidative stress-resistant cells are protected against haloperidol toxicity

Brain Research

Volumn 717, Issue 1-2, 1996, Pages 193-195

  Behl, C ^a   Lezoualc'h, F ^a   Widmann, M ^a   Rupprecht, R ^a   Holsboer, F ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

antioxidant enzyme; cytotoxicity; neuroleptic drug; oxidative stress; PC12

Indexed keywords

AMYLOID BETA PROTEIN; FREE RADICAL; HALOPERIDOL; NEUROLEPTIC AGENT;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; NEUROTOXICITY; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT;

EID: 0030009712     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00126-6     Document Type: Article

References (17)

1. Behl, C., Davis, J.B., Lesley, R. and Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity, Cell, 77 (1994) 817-827.
2. Behl, C., Rupprecht, R., Skutella, T. and Holsboer, F., Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro, NeuroReport, in press.
3. 2 receptors, Eur. J. Pharmacol., 177 (1990) 111-118.
4. Cadet, J.L., Lohr, J.B. and Jeste, D.V., Free radicals and tardive dyskinesia, Trends Neurosci., 9 (1986) 107-108.
5. Egan, M.F., Hyde, T.M., Albers, G.W., Elkashef, A., Alexander, P., Reeve, A., Blum, A., Saenz, R.E. and Wyatt, R.J., Treatment of tardive dyskinesia with vitamin E, Am. J. Psychiatry, 149 (1992) 773-777.
6. Glenner, G.G., Alzheimer's disease: its proteins and genes, Cell, 52 (1988) 307-308.
7. Greene, L.A. and Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor, Proc. Natl. Acad. Sci. USA, 73 (1976) 2424-2428.
8. Halliwell, B. and Gutteridge, J.M.C., Free Radicals in Biology and Medicine, Oxford University Press, 1989, 188-266 pp.
9. Hansen, M.B., Nielsen, S.E. and Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/killing, J. Immunol. Methods. 119 (1989) 203-210.
10. Jeding, I., Evans, P.J., Akanmu, D., Dexter, D., Spencer, J.D., Aruoma, O.I., Jenner, P. and Halliwell, B., Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs, Biochem. Pharmacol., 49 (1995) 359-365.
11. Olanow, C.W., A radical hypothesis for neurodegeneration, Trends Neurosci., 16 (1993) 439-444.
12. Peroutka, S.L. and Snyder, S.H.L., Relationship of neuroleptic drugs effects at brain dopamine, serotonin. adrenergic, and histamine receptors to clinical potency, Am. J. Psychiatry, 137 (1980) 1518-1527.
13. Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D. and Behl, C., Increased antioxidant enzyme activity in amyloid β protein-resistant cells, J. Neurosci., in press.
14. Su, T.P., σ receptors: putative links between nervous, endocrine and immune system, Eur. J. Biochem., 200 (1982) 633-642.
15. Shearman, M.S., Ragan, C.I. and Iversen, L.E., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death, Proc. Natl. Acad. Sci. USA, 91 (1994) 1470-1474.
16. Vilner, B.J. and Bowen, W.D., Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture, Eur. J. Pharmacol., 244 (1993) 199-201.
17. Vilner, B.J., deCosta, B.R. and Bowen, W.D., Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability, J. Neurosci., 15 (1995) 117-134.